P300 variations in parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300
- 31 October 1991
- journal article
- Published by Elsevier in Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section
- Vol. 80 (5) , 446-453
- https://doi.org/10.1016/0168-5597(91)90093-d
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Evoked potentials, reaction time and cognitive performance in on and off phases of Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- D1 and D2 dopamine agonist synergism: separate sites of action?Trends in Pharmacological Sciences, 1987
- Electrophysiological dfierences between demented and nondemented patients with Parkinson's diseaseAnnals of Neurology, 1987
- FRONTAL LOBE DYSFUNCTION IN PARKINSON'S DISEASEBrain, 1986
- Effect of fentanyl and naloxone on the P300 auditory potentialNeuropharmacology, 1984
- Cognition in Parkinson disease: An event‐related potential perspectiveAnnals of Neurology, 1982
- The immunocytochemical localization of enkephalin in the central nervous system of the ratJournal of Comparative Neurology, 1981
- Immunohistochemical localization of enkephalin in rat brain and spinal cordJournal of Comparative Neurology, 1978
- ParkinsonismNeurology, 1967
- Ascending Monoamine Neurons to the Telencephalon and DiencephalonActa Physiologica Scandinavica, 1966